East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for Aurobindo Receives FDA Approval Ramelteon Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), ROZEREM® Tablets manufactured by Takeda Pharmaceuticals USA Inc.

Ramelteon Tablets, are indicated for :

• Treatment of insomnia characterized by difficulty with sleep onset.